BELINDA CHILDS: Open Payments
NPI 1609969757 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 73 payments from 13 companies in 2025. Trend: 2023 $1,051 · 2024 $1,385 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 40 | $341 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $155 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Abbott Laboratories | 4 | $91 |
| Medtronic, Inc. | 3 | $91 |
| Corcept Therapeutics | 4 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Novo Nordisk Inc | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $50 |
Products named: Omnipod, Kerendia, WAINUA, FREESTYLE LIBRE 3, INTELLIS ADAPTIVESTIM, Korlym, GVOKE HYPOPEN, JARDIANCE.
Industry payments across KS — which companies pay providers there.
